Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic Restore

This article was originally published in The Gray Sheet

Executive Summary

Rechargeable neurostimulation system for chronic pain begins U.S. trial enrollment. The device features a battery that can last nine years and be recharged by the patient, potentially reducing needed follow-up visits. Medtronic currently offers Synergy, Itrel 3 and Mattrix neurostimulation devices for chronic pain. Rechargeable systems are offered by Advanced Neuromodulation Systems (Genesis) and Boston Scientific (Precision)...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts